1.
Achom M, Sadagopan A, Bao C, et al. A genetic basis for sex differences in Xp11 translocation renal cell carcinoma. Cell. 2024. doi:10.1016/j.cell.2024.07.038.
1.
Raghu A, Raghu A, Wise JF. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation. JMIR bioinformatics and biotechnology. 2024;5:e56538. doi:10.2196/56538.
1.
Priedigkeit N, Harrison B, Shue R, et al. Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.05.07.592972.
1.
Priedigkeit N, Harrison B, Shue R, et al. Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.05.07.592972.
1.
Prosz A, Duan H, Tisza V, et al. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.02.07.527498.
1.
Krill-Burger M, Dempster JM, Borah AA, et al. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome biology. 2023;24(1):192. doi:10.1186/s13059-023-03020-w.
1.
Qi M, Pang J, Mitsiades I, Lane AA, Rheinbay E. Loss of chromosome Y in primary tumors. Cell. 2023. doi:10.1016/j.cell.2023.06.006.